Bruker 過去の業績
過去 基準チェック /26
Brukerは、平均年間16.3%の収益成長を遂げていますが、 Life Sciences業界の収益は、年間 成長しています。収益は、平均年間11.7% 10.2%収益成長率で 成長しています。 Brukerの自己資本利益率は16.5%であり、純利益率は9.4%です。
主要情報
16.3%
収益成長率
17.6%
EPS成長率
Life Sciences 業界の成長 | 21.5% |
収益成長率 | 10.2% |
株主資本利益率 | 16.5% |
ネット・マージン | 9.4% |
前回の決算情報 | 30 Sep 2024 |
最近の業績更新
Bruker's (NASDAQ:BRKR) Anemic Earnings Might Be Worse Than You Think
Nov 14Bruker's (NASDAQ:BRKR) Promising Earnings May Rest On Soft Foundations
May 09Recent updates
Bruker's (NASDAQ:BRKR) Anemic Earnings Might Be Worse Than You Think
Nov 14Bruker: Still Challenged, Certainly Margins
Nov 02Earnings Tell The Story For Bruker Corporation (NASDAQ:BRKR)
Oct 25We Think Bruker (NASDAQ:BRKR) Is Taking Some Risk With Its Debt
Sep 10Bruker: Multiple Risks And Declining Returns On Capital Aren't Priced In
Aug 22Is It Too Late To Consider Buying Bruker Corporation (NASDAQ:BRKR)?
Jul 22Bruker Corporation's (NASDAQ:BRKR) Business Is Yet to Catch Up With Its Share Price
Jun 09Bruker: A Confusing Acquisition Spree
May 31Bruker's (NASDAQ:BRKR) Promising Earnings May Rest On Soft Foundations
May 09Bruker Corporation: An Aggressive Acquisition Strategy
Apr 24Bruker Offers Upside With Key Enabling Technologies For Future Bio-Pharma Research
Apr 11Calculating The Fair Value Of Bruker Corporation (NASDAQ:BRKR)
Jan 22There's Reason For Concern Over Bruker Corporation's (NASDAQ:BRKR) Price
Jan 08Should You Be Adding Bruker (NASDAQ:BRKR) To Your Watchlist Today?
Dec 26Is Bruker Corporation (NASDAQ:BRKR) Potentially Undervalued?
Nov 06Is Bruker (NASDAQ:BRKR) Using Too Much Debt?
Oct 23Here's Why Bruker (NASDAQ:BRKR) Has Caught The Eye Of Investors
Sep 25Does This Valuation Of Bruker Corporation (NASDAQ:BRKR) Imply Investors Are Overpaying?
Aug 09Is Now The Time To Look At Buying Bruker Corporation (NASDAQ:BRKR)?
Jul 27Bruker (NASDAQ:BRKR) Has A Pretty Healthy Balance Sheet
Jul 11収支内訳
収支内訳
Bruker の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
---|---|---|---|---|
30 Sep 24 | 3,241 | 305 | 855 | 356 |
30 Jun 24 | 3,120 | 352 | 804 | 329 |
31 Mar 24 | 3,001 | 402 | 762 | 308 |
31 Dec 23 | 2,965 | 427 | 730 | 295 |
30 Sep 23 | 2,818 | 319 | 687 | 275 |
30 Jun 23 | 2,715 | 319 | 644 | 260 |
31 Mar 23 | 2,621 | 312 | 625 | 248 |
31 Dec 22 | 2,531 | 297 | 608 | 236 |
30 Sep 22 | 2,506 | 275 | 598 | 231 |
30 Jun 22 | 2,476 | 274 | 605 | 226 |
31 Mar 22 | 2,458 | 282 | 577 | 223 |
31 Dec 21 | 2,418 | 277 | 563 | 221 |
30 Sep 21 | 2,362 | 270 | 544 | 220 |
30 Jun 21 | 2,264 | 238 | 518 | 216 |
31 Mar 21 | 2,118 | 204 | 485 | 204 |
31 Dec 20 | 1,988 | 158 | 472 | 198 |
30 Sep 20 | 1,960 | 158 | 470 | 188 |
30 Jun 20 | 1,970 | 165 | 480 | 185 |
31 Mar 20 | 2,035 | 177 | 503 | 190 |
31 Dec 19 | 2,073 | 197 | 500 | 188 |
30 Sep 19 | 2,026 | 207 | 491 | 186 |
30 Jun 19 | 1,972 | 189 | 473 | 182 |
31 Mar 19 | 1,925 | 184 | 459 | 177 |
31 Dec 18 | 1,896 | 180 | 449 | 173 |
30 Sep 18 | 1,873 | 98 | 443 | 172 |
30 Jun 18 | 1,842 | 92 | 440 | 171 |
31 Mar 18 | 1,813 | 84 | 432 | 167 |
31 Dec 17 | 1,766 | 79 | 420 | 162 |
30 Sep 17 | 1,706 | 151 | 407 | 157 |
30 Jun 17 | 1,664 | 161 | 399 | 154 |
31 Mar 17 | 1,621 | 152 | 396 | 151 |
31 Dec 16 | 1,611 | 154 | 394 | 148 |
30 Sep 16 | 1,619 | 146 | 393 | 148 |
30 Jun 16 | 1,621 | 111 | 393 | 144 |
31 Mar 16 | 1,646 | 119 | 390 | 145 |
31 Dec 15 | 1,624 | 102 | 392 | 146 |
30 Sep 15 | 1,654 | 66 | 408 | 151 |
30 Jun 15 | 1,677 | 60 | 420 | 158 |
31 Mar 15 | 1,739 | 55 | 436 | 165 |
31 Dec 14 | 1,809 | 57 | 451 | 174 |
30 Sep 14 | 1,853 | 66 | 451 | 182 |
30 Jun 14 | 1,872 | 77 | 449 | 185 |
31 Mar 14 | 1,870 | 83 | 441 | 187 |
31 Dec 13 | 1,839 | 80 | 438 | 191 |
質の高い収益: BRKRは 高品質の収益 を持っています。
利益率の向上: BRKRの現在の純利益率 (9.4%)は、昨年(11.3%)よりも低くなっています。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: BRKRの収益は過去 5 年間で年間16.3%増加しました。
成長の加速: BRKRは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。
収益対業界: BRKRは過去 1 年間で収益成長率がマイナス ( -4.5% ) となったため、 Life Sciences業界平均 ( -4.7% ) と比較することが困難です。
株主資本利益率
高いROE: BRKRの 自己資本利益率 ( 16.5% ) は 低い とみなされます。